Every Brilliant Thing Hits a Ticket Sales Wall With Tracee Ellis Ross
By Jennifer Chen | Posted on July 16, 2026 6:00 PM
Daniel Radcliffe and Mariska Hargitay Turned Every Brilliant Thing Into a Broadway Box Office Success. Can Tracee Ellis Ross Reverse a Shocking 57% Ticket Sales Decline?
Broadway’s Every Brilliant Thing was designed around an unusual commercial strategy: rotate major celebrities through the same solo role and sell each engagement as a separate theatrical event. The formula worked spectacularly well with Daniel Radcliffe and still remained somewhat effective with Mariska Hargitay. With Tracee Ellis Ross, however, the production has encountered a dramatic ticket sales collapse.
Ross’s first week, ending July 12, 2026 grossed just $485,981 in ticket sales across eight performances. That was a staggering 56.7% decline from the $1,121,871 earned during Hargitay’s seven-performance final week. The average ticket price plunged from $162.66 to $67.92, a drop of nearly 58.3%.
The theater was not empty: Ross attracted 7,155 patrons, slightly more than Hargitay’s final-week attendance of 6,897. But Ross had eight performances instead of seven, and the Hudson operated at only 90.71% capacity, compared with Hargitay’s virtually sold-out 99.93%. The problem was therefore not simply the number of people attending. It was how little many of them paid - some got a 50% discount, others paid nothing.

Daniel Radcliffe Created a Box-Office Monster
Radcliffe established a standard that neither successor was realistically expected to match. His final week grossed $2,296,473, with 7,885 people paying an extraordinary average of $291.25 per ticket. The production filled 99.96% of its available seats and set its highest weekly gross.
Radcliffe brought global recognition, a huge Harry Potter following and an established Broadway audience. His engagement also had scarcity on its side: fans knew exactly when his run would end and paid premium prices before he disappeared.
Mariska Hargitay Sustained the Show
Hargitay could not maintain Radcliffe’s extraordinary pricing, but she delivered strong business. Her first full week grossed $1,135,322, followed by weekly totals of $1,066,712, $1,050,974, $1,188,551 and $1,349,571. Her strongest regular week averaged $171.33 per ticket and filled 99.86% of the Hudson.
She brought a fiercely loyal Law & Order: SVU audience, decades of television familiarity and the curiosity surrounding her Broadway debut. Her engagement proved that the production could survive Radcliffe’s departure and still remain commercially substantial.

Tracee Ellis Ross Brings Recognition—but Not Premium Demand
Ross brings comic timing, warmth, fashion-world visibility and loyal followers from Girlfriends and black-ish. Artistically, she is well suited to the conversational and deeply personal material, but it was not to be the same success as her predecessors.
Commercially, though, her first-week numbers are unmistakably weak. Compared with Radcliffe’s final week, the gross fell almost 79%, while the average ticket price collapsed from $291.25 to $67.92. Even with respectable attendance, the show is now filling the Hudson largely through heavily reduced prices rather than premium demand.
The production already advertises $45 in-person and digital rush tickets, and the latest results explain why broader discounting would be necessary. Its shocking that the producers were giving tickets away for free, when they could have at least created a discount offer to claw back some revenue. The show was in last place for ticket sales on Broadway last week.
Producers Now Face a Familiar Broadway Decision
The production has already recouped its original $5.75 million capitalization, which removes some immediate financial pressure. Nevertheless, continuing to operate at roughly $486,000 per week may be unattractive compared with the seven-figure business produced by Hargitay and Radcliffe.
Ross is currently scheduled only through August 9, 2026. Producers could allow the show to close as planned, increase discounting to support the remaining performances, or recruit another celebrity capable of restoring decent ticket sales. Replacing a star or ending an engagement when revenue collapses is not unusual Broadway behavior—it is the economic logic behind the show’s entire rotating-cast model.